Found: 75
Select item for more details and to access through your institution.
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 2956, doi. 10.1093/rheumatology/keae394
- By:
- Publication type:
- Article
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 2948, doi. 10.1093/rheumatology/keae390
- By:
- Publication type:
- Article
Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 2, p. 71, doi. 10.1002/acr2.11515
- By:
- Publication type:
- Article
Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1761-2
- By:
- Publication type:
- Article
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1445-3
- By:
- Publication type:
- Article
Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 6, p. 2894, doi. 10.3390/ijms22062894
- By:
- Publication type:
- Article
Unmet foot health needs in people with Systemic Sclerosis: an audit of foot health care provision.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?
- Published in:
- Postgraduate Medical Journal, 2012, v. 88, n. 1042, p. 482, doi. 10.1136/postgradmedj-2011-201048rep
- By:
- Publication type:
- Article
Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach.
- Published in:
- Drugs, 2020, v. 80, n. 9, p. 849, doi. 10.1007/s40265-020-01309-9
- By:
- Publication type:
- Article
Management of systemic sclerosis: British Society for Rheumatology guideline scope.
- Published in:
- Rheumatology Advances in Practice, 2023, v. 7, n. 1, p. 1, doi. 10.1093/rap/rkad022
- By:
- Publication type:
- Article
Single-centre experience of refractory rheumatoid arthritis.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac057
- By:
- Publication type:
- Article
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 8, p. 2361, doi. 10.1007/s10067-022-06176-1
- By:
- Publication type:
- Article
Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales.
- Published in:
- Clinical Rheumatology, 2012, v. 31, n. 6, p. 1005, doi. 10.1007/s10067-011-1936-6
- By:
- Publication type:
- Article
Foot health needs in people with systemic sclerosis: an audit of foot health care provision.
- Published in:
- Clinical Rheumatology, 2011, v. 30, n. 12, p. 1611, doi. 10.1007/s10067-011-1784-4
- By:
- Publication type:
- Article
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60314-w
- By:
- Publication type:
- Article
Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations.
- Published in:
- Drug, Healthcare & Patient Safety, 2010, v. 2, p. 101, doi. 10.2147/DHPS.S6317
- By:
- Publication type:
- Article
Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis.
- Published in:
- Arthritis Care & Research, 2012, v. 64, n. 1, p. 66, doi. 10.1002/acr.20553
- By:
- Publication type:
- Article
The 'therapeutic window' and treating to target in rheumatoid arthritis.
- Published in:
- Clinical Medicine, 2013, v. 13, n. 4, p. 387
- By:
- Publication type:
- Article
The 'therapeutic window' and treating to target in rheumatoid arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Relationship Between Synovial Pathobiology and Magnetic Resonance Imaging Abnormalities in Rheumatoid Arthritis: A Systematic Review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. 3133, doi. 10.1093/rheumatology/kead012
- By:
- Publication type:
- Article
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review.
- Published in:
- Rheumatology, 2022, v. 61, n. 8, p. 3132, doi. 10.1093/rheumatology/keac049
- By:
- Publication type:
- Article
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2596, doi. 10.1093/rheumatology/keab676
- By:
- Publication type:
- Article
First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosis.
- Published in:
- Rheumatology, 2022, v. 61, n. 4, p. 1651, doi. 10.1093/rheumatology/keab567
- By:
- Publication type:
- Article
Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the 'VEDERA' trial.
- Published in:
- Rheumatology, 2022, v. 61, n. 2, p. 868, doi. 10.1093/rheumatology/keab766
- By:
- Publication type:
- Article
Changes in the pharmacological management of rheumatoid arthritis over two decades.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4141, doi. 10.1093/rheumatology/keaa892
- By:
- Publication type:
- Article
Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4048, doi. 10.1093/rheumatology/keaa858
- By:
- Publication type:
- Article
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3679, doi. 10.1093/rheumatology/keaa834
- By:
- Publication type:
- Article
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
- Published in:
- Rheumatology, 2021, v. 60, n. 7, p. 3209, doi. 10.1093/rheumatology/keaa770
- By:
- Publication type:
- Article
Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.
- Published in:
- Rheumatology, 2021, v. 60, n. 6, p. 2934, doi. 10.1093/rheumatology/keaa742
- By:
- Publication type:
- Article
Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2040, doi. 10.1093/rheumatology/keaa840
- By:
- Publication type:
- Article
Muscle deterioration due to rheumatoid arthritis: assessment by quantitative MRI and strength testing.
- Published in:
- Rheumatology, 2021, v. 60, n. 3, p. 1216, doi. 10.1093/rheumatology/keaa364
- By:
- Publication type:
- Article
Abnormal electrophysiological testing associates with future incidental significant arrhythmia in scleroderma.
- Published in:
- Rheumatology, 2020, v. 59, n. 4, p. 899, doi. 10.1093/rheumatology/kez434
- By:
- Publication type:
- Article
Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 9, p. 1684, doi. 10.1093/rheumatology/kez114
- By:
- Publication type:
- Article
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 8, p. 1400, doi. 10.1093/rheumatology/kez049
- By:
- Publication type:
- Article
Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP.
- Published in:
- Rheumatology, 2019, v. 58, n. 7, p. 1221, doi. 10.1093/rheumatology/key430
- By:
- Publication type:
- Article
231 Serum interferon score predicts clinical outcome at 12 months in diffuse cutaneous systemic sclerosis as measured by Global Ranked Composite Score (GRCS) and Composite Response Index in SSc (CRISS).
- Published in:
- 2019
- By:
- Publication type:
- Abstract
089 Single centre cohort of refractory rheumatoid arthritis also identifies a rare subgroup of multiple targeted therapy class non-response.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
191 Effectiveness and safety of switch to rituximab biosimilar with rheumatoid arthritis. a single centre experience.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
087 Janus kinase inhibitors demonstrate effectiveness in a real-world multi-biologic DMARD refractory rheumatoid arthritis population.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
085 Mapping between the American College of Rheumatology 20/50/70 and (change in) Disease Activity Score-28 in rheumatoid arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 254, doi. 10.1093/rheumatology/key271
- By:
- Publication type:
- Article
Primary myocardial disease in scleroderma--a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.
- Published in:
- Rheumatology, 2017, v. 56, n. 6, p. 882, doi. 10.1093/rheumatology/kew488
- By:
- Publication type:
- Article
Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study.
- Published in:
- Rheumatology, 2017, v. 56, n. 1, p. 58, doi. 10.1093/rheumatology/kew357
- By:
- Publication type:
- Article
Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
- Published in:
- Rheumatology, 2016, v. 55, n. 12, p. 2273, doi. 10.1093/rheumatology/kew362
- By:
- Publication type:
- Article
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis--results from the IDEA study.
- Published in:
- Rheumatology, 2016, v. 55, n. 12, p. 2181, doi. 10.1093/rheumatology/kew306
- By:
- Publication type:
- Article
BSR and BHPR guideline for the treatment of systemic sclerosis.
- Published in:
- Rheumatology, 2016, v. 55, n. 10, p. 1906, doi. 10.1093/rheumatology/kew224
- By:
- Publication type:
- Article
Discordance between the predictors of clinical and imaging remission in patients with early rheumatoid arthritis in clinical practice: implications for the use of ultrasound within a treatment-to-target strategy.
- Published in:
- Rheumatology, 2016, v. 55, n. 7, p. 1177, doi. 10.1093/rheumatology/kew037
- By:
- Publication type:
- Article
The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Correction Notice
The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article